Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT00231556
Eligibility Criteria:
Inclusion Criteria:
* Weigh \>=25 kilograms
* Diagnosis of epilepsy within 3 months prior to study entry or recurrence of epilepsy while off of anit-epileptic drugs
* No more than two documented seizures during the three-month retrospective baseline phase
* may have experienced seizures prior to the three-month, retrospective baseline phase
* Patients with partial-onset seizures, with or without a secondarily generalized component, and generalized seizures, including tonic-clonic (grand mal), tonic, clonic, juvenile myoclonic epilepsy (impulsive petit mal) and myoclonic epilepsy
* Receiving either no other concomitant anti-epileptic drug (AED) or be on one standard AED.
Exclusion Criteria:
* Patients who do not have epilepsy
* Patients with absence (petit mal) or atypical absence seizures, epilepsia paritlis continua, cluster pattern or serial seizures
* Patients with progressive neurological or degenerative disorder
* Patients with significant history of unstable medical diseases
* Patients with a drug allergy or hypersensitivity to carbonic anhydrase inhibitors or sulfa drugs
* Patients with history of alcohol or drug abuse within past one year
* Patients with a history of suicide attempt within past one year.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00231556
Study Brief:
Protocol Section:
NCT00231556